No announcement yet.

Spinal cord injury expert shares research

  • Filter
  • Time
  • Show
Clear All
new posts

    Spinal cord injury expert shares research

    Miami Project has nothing new to offer.

    Spinal cord injury expert shares research

    by Cindy Abole
    Public Relations

    The MUSC research community learned the latest developments about a promising hypothermia trial to treat acute spinal cord injuries during the July 8 visit of a leading researcher with The Miami Project.

    Dr. Allan Levi, left, is met by Dr. Tom Higerd and the South Carolina Spinal Cord Injury Research Fund's Board of Directors as part of Levi's July 8 visit to MUSC.

    Allan D. Levi, M.D., Ph.D., professor of neurosurgery and chief of the neurospine service at Jackson Memorial Hospital, spoke at a recent Department of Neurosciences Grand Rounds and met with the South Carolina Spinal Cord Injury Research Fund’s (SCIRF) board. He came to highlight the results of a hypothermia trial that he and colleagues at the University of Miami Jackson Memorial Medical Center conducted.

    The trial involves systemic intravascular cooling by introducing a cold saline solution to decrease damage to the spinal cord in severe cases of cervical spinal cord injury patients. The treatment also may be neuroprotective in that it decreases the severity of injury and increases function in patients. Other clinical reports have demonstrated the use of cooling on patients with head injury, stroke and cardiac arrest, but presented no established standards of care for those with spinal cord injuries. Levi and his research team’s findings were published in the April issue of Neurosurgery.

    Levi’s visit was coordinated under the guidance of Brian G. Cuddy, M.D., a Lowcountry neurosurgeon and SCIRF board chair. In addition to his grand rounds talk, Levy focused on education and the national research mission of The Miami Project in advancing knowledge and treatments in spinal cord injury research.

    Cuddy said that the visit served as a catalyst.